These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 9590393
1. Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry. Warner A, Privitera M, Bates D. Clin Chem; 1998 May; 44(5):1085-95. PubMed ID: 9590393 [Abstract] [Full Text] [Related]
3. Practical considerations in anticonvulsant therapy--Part 2. Meyer MC, Cloyd J, Garnett WR, Holmes GL, Schiffer JR. Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814 [Abstract] [Full Text] [Related]
4. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, Perucca E. Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121 [Abstract] [Full Text] [Related]
5. Rational use of antiepileptic drug levels. Theodore WH. Pharmacol Ther; 1992 Feb; 54(3):297-305. PubMed ID: 1465479 [Abstract] [Full Text] [Related]
6. Therapeutic drug monitoring of antiepileptic drugs. Shakya G, Malla S, Shakya KN, Shrestha R. JNMA J Nepal Med Assoc; 2008 Feb; 47(171):94-7. PubMed ID: 19079370 [Abstract] [Full Text] [Related]
8. Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum. Steijns LS, Bouw J, van der Weide J. Ther Drug Monit; 2002 Jun; 24(3):432-5. PubMed ID: 12021637 [Abstract] [Full Text] [Related]
14. The use of blood levels of antiepileptic drugs in clinical practice. Kutt H. Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906 [No Abstract] [Full Text] [Related]
15. Relationship between dose and serum concentrations of carbamazepine, phenytoin, phenobarbital, and primidone in a Sri Lankan population compared with a European population. Peiris JB, Karunanayake EH, Joice PD, Goedhart DM, Meijer JW, Meinardi H. Epilepsia; 1988 Apr; 29(5):564-70. PubMed ID: 3409842 [Abstract] [Full Text] [Related]
16. Performance of fluorescence polarisation immunoassay reagents for carbamazepine, phenytoin, phenobarbitone, primidone, and valproic acid on a Cobas Fara II analyser. Stamp RJ, Mould GP, Müller C, Burlina A. Ther Drug Monit; 1991 Nov; 13(6):518-22. PubMed ID: 1771649 [Abstract] [Full Text] [Related]
17. Recent advances in drug therapy for epilepsy. Bruni J. Can Med Assoc J; 1979 Apr 07; 120(7):817-24. PubMed ID: 371777 [Abstract] [Full Text] [Related]
18. Evaluation of therapeutic drug monitoring of antiepileptic drugs. Irshaid YM, Hamdi AA, Al Homrany M. Int J Clin Pharmacol Ther; 2003 Mar 07; 41(3):126-31. PubMed ID: 12665161 [Abstract] [Full Text] [Related]
19. Concurrent determination of valproic acid with other antiepileptic drugs by high-performance liquid chromatography. Kushida K, Ishizaki T. J Chromatogr; 1985 Feb 27; 338(1):131-9. PubMed ID: 3926800 [Abstract] [Full Text] [Related]
20. Investigation of phenobarbital-carbamazepine-valproic acid interactions using population pharmacokinetic analysis for optimisation of antiepileptic drug therapy: an overview. Yukawa E. Drug Metabol Drug Interact; 2000 Feb 27; 16(2):86-98. PubMed ID: 10962642 [Abstract] [Full Text] [Related] Page: [Next] [New Search]